Patents by Inventor Sairam V.V.M. Kalapatapu

Sairam V.V.M. Kalapatapu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11225480
    Abstract: The present invention relates to novel compounds useful as malic enzyme (ME) inhibitors, processes for their preparation and use of these compounds for the therapeutic treatment of disorders mediated by ME such as cancers (e.g. pancreatic ductal adenocarcinoma (PDAC)) in humans. The novel compounds have a structure according to Formula I or a pharmaceutically acceptable salt, stereoisomer or deuterated analog thereof, wherein X, R1, R2 and Y are as described herein.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: January 18, 2022
    Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTD
    Inventors: Gaurav Sanjivkumar Sheth, Sabbirhusen Yusufbhai Chimanwala, Tushar Mukund Jarag, Aishwarya Hampiholi, Saikat Maity, Prabal Sengupta, Gulamnizami Abdulsattar Qureshi, Umesh Vishnu Chaudhari, Raj Gopal Venkat, V. S. N. Murty Kadiyala, Sairam V V M Kalapatapu, Vaibhav Jain, Trinadha Rao Chitturi
  • Patent number: 9273041
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The present invention is directed to compounds suitable for the treatment of Disease conditions such as hyperlipidemia.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: March 1, 2016
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pankaj Makadia, Vrajesh Pandya, Sairam V. V. M. Kalapatapu
  • Publication number: 20150099696
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The present invention is directed to compounds suitable for the treatment of Disease conditions such as hyperlipidemia.
    Type: Application
    Filed: June 26, 2012
    Publication date: April 9, 2015
    Applicant: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pankaj Makadia, Vrajesh Pandya, Sairam V.V.M. Kalapatapu